Record Day for Tests
Sativa Wellness Group (OTC PINK:SCNNF) reported a record day with over 850 tests booked, generating approximately C$180,000 (£100,000) in revenue. The majority of tests continue to be COVID-19 related, but blood tests are increasingly in demand. The company expects sustained demand for PCR tests due to government requirements in 220 countries, and anticipates growth in its blood testing services as additional clinics open and test offerings expand. This surge in testing reflects strong operational capacity and customer satisfaction.
- Record day with over 850 tests booked.
- Revenue of approximately C$180,000 reported.
- Growing demand for blood tests alongside COVID-19 tests.
- Future expansion anticipated in blood testing services.
- None.
VANCOUVER, BC / ACCESSWIRE / October 20, 2021 / Sativa Wellness Group Inc. (CSE:SWEL)(OTC PINK:SCNNF) ("Sativa Wellness" or the "Company") is pleased to announce that Monday this week saw the highest number of tests booked in a day exceeding 850 tests and C
Geremy Thomas, Executive Chairman, says; "The 850 Customers received excellent treatment at the hands of our amazing staff and pharmacy partners as demonstrated by our ratings and reviews. Our order books are full, and we are enabling more and more pharmacies as fast as we can to help families looking forward to their ‘half-term' holiday."
The Directors of the Company accept responsibility for the contents of this announcement.
On behalf of the Board of Directors,
Marc Howells Chief Executive Officer Sativa Wellness Group Inc. +44 (0) 20 7971 1255 enquiries@sativawellnessgroup.com www.sativawellnessgroup.com | Anne Tew Chief Financial Officer Sativa Wellness Group Inc. +44 (0) 20 7971 1255 enquiries@sativawellnessgroup.com www.sativawellnessgroup.com |
Neither the Canadian Securities Exchange nor its Market Regulator (as defined in the policies of the Canadian Securities Exchange) accept responsibility for the adequacy or accuracy of this release. This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Sativa's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" "plan is" or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur", "will be achieved" or "shortly". The forward-looking information and forward-looking statements contained herein include, but are not limited to The demand for PCR tests requested by the governments of the 220 countries outside the UK is expected to continue into next year. Although Sativa believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this press release, and include but are not limited to the demand for PCR tests requested by the governments of the 220 countries outside the UK is expected to continue into next year and the blood testing part of the business will have time to fully develop during this period as more clinics come online and the range of tests expands.
Sativa does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.
SOURCE: Sativa Wellness Group Inc.
View source version on accesswire.com:
https://www.accesswire.com/668879/Record-Day-for-Tests
FAQ
What was the revenue reported by Sativa Wellness Group for October 2021?
How many tests did Sativa Wellness Group book on their record day?
What type of tests are primarily being conducted by Sativa Wellness Group?
What is the outlook for PCR testing demand according to Sativa Wellness Group?